Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): Report from the Children's cancer group

Cancer Causes and Control

Volumn 7, Issue 6, 1996, Pages 581-590

  Ross, Julie A ^a,e   Potter, John D ^b   Reaman, Gregory H ^c   Pendergrass, Thomas W ^d   Robison, Leslie L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^e CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

11q23; Canada; Diet; DNA topoisomerases; Epipodophyllotoxins; Infant leukemia; United States

Indexed keywords

CAFFEINE; CATECHIN; DNA TOPOISOMERASE (ATP HYDROLYSING); EPIPODOPHYLLOTOXIN; GENISTEIN; GYRASE INHIBITOR; PODOPHYLLIN; QUERCETIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ARTICLE; CANADA; CHILD; CHROMOSOME DISORDER; CONTROLLED STUDY; DIET; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; HUMAN; INFANT; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNITED STATES;

ACUTE DISEASE; CANADA; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 11; CONFIDENCE INTERVALS; DIET; DNA TOPOISOMERASES, TYPE II; DRUG THERAPY; FEMALE; FOLLOW-UP STUDIES; FOOD; GENES; HUMANS; INFANT; INTERVIEWS; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; MATERNAL EXPOSURE; ODDS RATIO; PREGNANCY; QUESTIONNAIRES; UNITED STATES;

EID: 0029910797     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00051700     Document Type: Article

References (27)

1. Bader JL, Miller RW. US cancer incidence and mortality in the first year of life. Am J Dis Child 1979; 133: 157-9.
2. Ross JA, Davies SM, Potter JD, Robison LL. Childhood leukemia with a focus on infants. Epidemiol Rev 1994; 16: 243-72.
3. Ford AM, Ridge SA, Cabrera ME, et al. In utero rearrangements in the trithorax-related oncogene in infant leukemias. Nature 1993; 363: 358-60.
4. Pui CH, Behm FG, Raimondi SC, et al. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med 1989; 321: 136-42.
5. Kumar L. Epipodophyllotoxins and secondary leukemia. Lancet 1993; 342: 819-20.
6. Felix CA, Winick NJ, Negrini M, Bowman WP, Croce CM, Lange, BJ. Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia. Cancer Res 1993; 53: 2954-6.
7. Long BH. Mechanisms of action of teniposide (VM-26) and comparison with etoposide (VP-16). Semin Oncol 1992; 19: s3-s19.
8. Gerwitz DA. Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors? Biochem Pharmacol 1991; 42: 2253-8.
9. Yamashita T, Kawada SZ, Nakano H. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem Pharm 1990; 39: 737-44.
10. Pierpoint WS. Flavonoids in the human diet. In: Cody V, Middleton Jr E, Harborne JB, eds. Plant Flavonoids in Biology and Medicine, Biochemical, Pharmacological, and Structure-Activity Relationships. New York, NY (USA): Alan R. Liss, Inc., 1986: 125-40.
11. Pommier Y, Bertrand R. The mechanisms of formation of chromosomal aberrations: role of eukaryotic DNA topoisomerases. In: Kirsch LR, ed. The Causes and Consequences of Chromosomal Aberrations. Boca Raton, FL (USA): CRC Press, Inc., 1993: 277-309.
12. Austin CA, Patel S, Ono K, Nakane H, Fisher LM. Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives. Biochem J 1992; 282: 883-9.
13. Shin CG, Strayer JM, Wani MA, Snapka RM. Rapid evaluation of topoisomerase inhibitors: caffeine inhibition of topoisomerases in vivo. Teratogen Carcinog Mutagen 1990; 10: 41-52.
14. Epstein RJ. Topoisomerases in human disease. Lancet 1988; ii: 521-3.
15. Ling MR. Therapy of genital human papillomavirus infections. Part II: methods of treatment. Int J Dermatol 1992; 31: 769-77.
16. Ferguson LR, Peason A. Chromosomal changes in Chinese hamster AA8 cells caused by podophyllin, a common treatment for genital warts. Mutat Res 1992; 266: 231-9.
17. Ross JA, Potter JD, Robison LL. Infant leukemia, topoisomerase II inhibitors, and the MLL gene. JNCI 1994; 86: 1678-80.
18. Robison LL, Buckley JD, Bunin G. Assessment of environmental and genetic factors in the etiology of childhood cancers: The Children's Cancer Group Epidemiology Program. Environ Health Perspect 1995; 103: 111-6.
19. Shu XO, Reaman GH, Lampkin B, Sather HN, Pendergrass TW, Robison LL. Association of parental diagnostic x-ray exposure with risk of infant leukemia. Cancer Epidemiol Biomark Prev 1994; 3: 645-53.
20. Buckley JD, Robison LL, Swotinsky R, et al. Occupational exposures of parents of children with acute nonlymphocytic leukemia: a report from the Children's Cancer Study Group. Cancer Res 1989; 49: 4030-7.
21. Robison LL, Buckley JD, Daigle AE, et al. Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana. (A report from the Children's Cancer Study Group). Cancer 1989; 63: 1904-11.
22. Ross JA, Severson RK, Robison LL, et al. Pediatric cancer in the United States: a preliminary report of a collaborative study of the Children's Cancer Group and the Pediatric Oncology Group. Cancer 1993; 71: 3415-21.
23. Robison LL, Daigle AE. Control selection using random digit dialing for cases of childhood cancer. Am J Epidemiol 1984; 12: 164-6.
24. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol 1. The Analysis of Case-control Studies. Lyon, France: International Agency for Research on Cancer, 1980; IARC Sci. Pub. No. 32.
25. Rohan TE, Potter JD. Retrospective assessment of dietary intake. Am J Epidemiol 1984; 120: 876-87.
26. Jensen OM, Wahrendorf J, Rosenqvist A, Geser A. The reliability of questionnaire-derived historic dietary information and temporal stability of food habits in individuals. AmJ Epidemiol 1984; 120: 281-90.
27. Lowengart RA, Peters JM, Cicioni C, et al. Childhood leukemia and parents' occupational and home exposure. JNCI 1987; 79: 39-46.